SC AG Files Lawsuit Against GSK for Improper Marketing of Diabetes Drug

The Associated Press (6/1/11) reported that South Carolina Attorney General Alan Wilson filed suit May 17, 2011 against GlaxoSmithKline (GSK), alleging that GSK had improperly marketed the diabetes drug Avandia (rosiglitazone) to South Carolina consumers and hid the medication’s harmful side effects.  In his complaint, Wilson argues “that the drugmaker acted negligently when it claimed that Avandia did not put patients’ hearts at risks and could actually reduce the potential for heart problems.”